Organisation paid for research Program year 2022 Source: CMS Open Payments

Atlantis Eye Care

Neither a doctor nor a teaching hospital

Research payments

$11,192

15 payments

Through program year 2022, Atlantis Eye Care is reported as receiving $11,192 in research payments, across 15 payments.

By program year

3 rows

Year	Kind	Amount	Payments
2022	Research	$6,734	5
2021	Research	$832	1
2019	Research	$3,627	9

Breakdown

Who paid Research payments · program years 2019–2022

AbbVie, Inc. $6,734 5 payments
Allergan Inc. $4,459 10 payments

Studies the money was for Research payments · program years 2019–2022

Evaluation of the Duration of Effect of Bimatoprost SR in Participants With Open-Angle Glaucoma or Ocular Hypertension $6,734 5 payments
Efficacy and Safety of Bimatoprost Sustained-Release Sr in Patients With Open-Angle Glaucoma Or Ocular Hypertension $3,220 8 payments
A multicenter, open-label, single arm study in patients with open angle glaucoma or ocular hypertension who have not had previous laser trabeculoplasty treatment $832 1 payment
A Comparison of Bimatoprost SR to Selective Laser Trabeculoplasty in Patients with Open-Angle Glaucoma or Ocular Hypertension $407 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.